BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9169098)

  • 1. Detection of Epstein-Barr viral DNA in serum using rapid-cycle PCR.
    Mouritsen CL; Wittwer CT; Reed G; Khan TM; Martins TB; Jaskowski TD; Litwin CM; Hill HR
    Biochem Mol Med; 1997 Apr; 60(2):161-8. PubMed ID: 9169098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hospital based pilot study on Epstein-Barr virus in suspected infectious mononucleosis pediatric patients in India.
    Janani MK; Malathi J; Appaswamy A; Singha NR; Madhavan HN
    J Infect Dev Ctries; 2015 Oct; 9(10):1133-8. PubMed ID: 26517489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus PCR correlated with viral histology and serology in pediatric liver transplant patients.
    Rogers BB; Conlin C; Timmons CF; Dawson DB; Krisher K; Andrews WS
    Pediatr Pathol Lab Med; 1997; 17(3):391-400. PubMed ID: 9185219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of three ELISA techniques and an indirect immunofluorescence assay for the serological diagnosis of Epstein-Barr virus infection.
    Debyser Z; Reynders M; Goubau P; Desmyter J
    Clin Diagn Virol; 1997 May; 8(1):71-81. PubMed ID: 9248660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
    Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M
    J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between results of PCR and specific serological tests in diagnosis of Epstein-Barr virus in patients with mononucleosis syndrome].
    Banko AV; Lazarević IB; Cupić MD; Knezević AM; Stevanović GD; Krejović-Trivić SB; Jovanović TP
    Acta Chir Iugosl; 2009; 56(3):71-6. PubMed ID: 20218106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avidities of IgG directed against viral capsid antigen or early antigen: useful markers for significant Epstein-Barr virus serology.
    Andersson A; Vetter V; Kreutzer L; Bauer G
    J Med Virol; 1994 Jul; 43(3):238-44. PubMed ID: 7931184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Abbott Architect, Siemens Immulite, bioMerieux Vidas, and Euroimmune assays for determination of Epstein-Barr virus serological diagnosis.
    Appak O; Ozkaratas MH; Sayiner AA
    J Med Virol; 2021 Nov; 93(11):6309-6316. PubMed ID: 34375007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of four commercial systems for the diagnosis of Epstein-Barr virus primary infections.
    de Ory F; Guisasola ME; Sanz JC; García-Bermejo I
    Clin Vaccine Immunol; 2011 Mar; 18(3):444-8. PubMed ID: 21191077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.
    Cao P; Zhang M; Wang W; Dai Y; Sai B; Sun J; Wang L; Wang F; Li G; Xiang J
    BMC Infect Dis; 2017 May; 17(1):323. PubMed ID: 28468603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
    Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a new Epstein-Barr virus Combi Test for rapid serologic diagnosis of infectious mononucleosis.
    Dobec M; Peltier A; Levy J; Decolvenaer M; Hansen V; Beers DV; Butzler JP; Hausler WJ
    Zentralbl Bakteriol; 1996 Aug; 284(4):565-76. PubMed ID: 8899975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Importance and diagnosis of Epstein-Barr virus infection].
    Kuljić-Kapulica N; Krstić L; Budisin A; Kapulica I; Bojić I; Malesević M; Kalinić-Andrić V
    Vojnosanit Pregl; 1991; 48(4):313-6. PubMed ID: 1660212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of the new ARCHITECT EBV assays considering different testing algorithms.
    Sickinger E; Berth M; Vockel A; Braun HB; Oer M; Buenning C
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):310-6. PubMed ID: 24809858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection.
    Obel N; Høier-Madsen M; Kangro H
    APMIS; 1996 Jun; 104(6):424-8. PubMed ID: 8774671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.